论文部分内容阅读
目的观察优泌乐50与优泌乐25治疗糖尿病降低餐后血糖水平的临床效果。方法选取63例糖尿病患者,随机分为实验组(32例)和对照组(31例)。两组患者均予以常规饮食治疗和健康教育,在此基础上观察组给予优泌乐50餐前皮下注射,对照组给予优泌乐25餐前皮下注射,连续1周记录两组患者注射优泌乐后餐后血糖的变化情况,分析比较优泌乐50与优泌乐25降低餐后血糖的临床效果。结果两组患者治疗1周后的空腹血糖水平均降低,但差异无统计学意义(P>0.05),治疗后两组患者的日常三餐的餐后2 h血糖水平也均降低,观察组患者餐后血糖水平明显低于对照组,差异具有统计学意义(P<0.05)。结论优泌乐50降低餐后血糖水平的效果明显较优泌乐25优越。
Objective To observe the clinical effects of Uehara 50 and Uehara 25 on reducing the postprandial blood glucose level in patients with diabetes mellitus. Methods 63 cases of diabetic patients were randomly divided into experimental group (32 cases) and control group (31 cases). Both groups were given routine dietary therapy and health education. On this basis, the observation group was given subcutaneous instillation of Urged 50 before meal, the control group was given subcutaneous instillation of Uehara 25 before meals, and the patients in two groups were injected for one week Postprandial postprandial blood glucose changes, analysis and comparison of the excellent secretion of 50 and Youji Le 25 to reduce postprandial blood glucose clinical effect. Results After 1 week of treatment, fasting blood glucose levels decreased in both groups, but the difference was not statistically significant (P> 0.05). After 2 weeks of treatment, both groups’ Postprandial blood glucose levels were significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion Youji 50 reduce the effect of postprandial blood glucose levels were significantly superior to the superior secretion of Le 25.